MI

Mitsubishi Research Institute, Inc.

A think tank providing research, consulting, and ICT solutions to public & private sectors.

3636 | T

Overview

Corporate Details

ISIN(s):
JP3902200009
LEI:
Country:
Japan
Address:
千代田区永田町二丁目10番3号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Mitsubishi Research Institute, Inc. (MRI), established in 1970, is a prominent Japanese think tank and consulting firm. As a core member of the Mitsubishi Group, MRI provides integrated services encompassing research, consulting, and ICT solutions to both public and private sector clients. The firm specializes in developing comprehensive solutions to address complex societal and business challenges. MRI leverages its extensive expertise to support clients globally, with significant experience in Asia and the Middle East, aiming to contribute to a prosperous and sustainable society.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 06:18
Major Shareholding Notification
変更報告書
Japanese 56.2 KB
2025-06-03 07:27
Major Shareholding Notification
変更報告書
Japanese 54.5 KB
2025-04-25 09:14
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-04-25 09:12
Interim Report
半期報告書-第56期(2024/10/01-2025/09/30)
Japanese 212.8 KB
2024-12-19 06:02
Regulatory News Service
臨時報告書
Japanese 25.9 KB
2024-12-11 02:25
Registration Form
確認書
Japanese 8.1 KB
2024-12-11 02:24
Governance Information
内部統制報告書-第55期(2023/10/01-2024/09/30)
Japanese 22.3 KB
2024-12-11 02:22
Annual Report
有価証券報告書-第55期(2023/10/01-2024/09/30)
Japanese 2.8 MB
2024-04-26 06:41
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-04-26 06:39
Quarterly Report
四半期報告書-第55期第2四半期(2024/01/01-2024/03/31)
Japanese 212.4 KB
2024-02-06 05:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-02-06 05:30
Quarterly Report
四半期報告書-第55期第1四半期(2023/10/01-2023/12/31)
Japanese 161.5 KB
2023-12-20 06:46
Post-Annual General Meeting Information
臨時報告書
Japanese 28.2 KB
2023-12-19 06:01
Registration Form
確認書
Japanese 8.1 KB
2023-12-19 06:00
Governance Information
内部統制報告書-第54期(2022/10/01-2023/09/30)
Japanese 22.3 KB

Automate Your Workflow. Get a real-time feed of all Mitsubishi Research Institute, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mitsubishi Research Institute, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mitsubishi Research Institute, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America
M3D
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.